Psyched Wellness Provides Update On Pre-Clinical Trial of Its Muscimol Extract AME-1

New industries are being formed every few months and if investors are to get in early into potentially fast-growing industries at the starting point then it is necessary to be as well informed as possible.

There are a lot of resources on the internet that can help in this regard and over the past months, the YouTube channel Rich Tv Live has emerged as a reliable source of information.

Key Details

Enter Your E-mail Address To Subscribe

* indicates required

In its latest video, the Rich Tv host showcased the company Psyched Wellness (CSE:PSYC) OTCQB:PSYCF) (FRANKFURT:5U9), which is involved in producing and distributing functional as well as psychedelic mushrooms. It is an up-and-coming industry that could eventually have considerable upside, which is possibly the reason why Psyched Wellness was covered by Rich Tv.

More importantly, the channel also got the Chief Executive Officer Jeff Stevens to participate in a chat and he laid out the aims of the company quite succinctly. It is a video that could be a great introduction for investors into the workings of Psyched Wellness.

On the other hand, there was an important development with regards to the company on Wednesday as well and that makes the timing of the video quite crucial. The company announced yesterday that it received the results from the Maximum Tolerance Dosage study that had been conducted into its product recently.

The study was conducted by a CRO in Canada. Jeff Stevens stated that the results were positive. He went on to state that it means that Psyched Wellness is now a step further in its goal of applying to the United States Food and Drug Administration for a New Dietary Ingredient license.

In addition to that, the company is also going to apply to the Canadian regulatory authority Health Canada in order to get a Natural Health Product Number. Hence, it goes without saying that the latest set of positive results marks a massive development for Psyched Wellness.

The company is trying to become one of the major players in the still-nascent psychedelic-based medicine and wellness industry. Stevens was quite forthright about his views regarding the future of the industry in general and the company in particular. Interested investors could consider going through the video on YouTube.

Featured image: Pixabay

Please See Disclaimer

If You Liked This Article Click To Share

Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of or its officers. The author is wholly responsible for the validity of all statements. was not involved in any aspect of the article preparation. The author was not paid by Bitrex Inc for this article. The author did not pay to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. does not render general or specific investment advice. Any information on should not be considered a recommendation to buy or sell any security. does not endorse or recommend the business, products, services or securities of any company mentioned on

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.